ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1969–1980 of 2020 project topics
Collagen Type I Mutation Screening Commercial Platform
A comprehensive screening platform that identifies COL1A1 and COL1A2 mutations associated with osteogenesis imperfecta and related collagen disorders using automated interpretation algorithms. The platform captures market demand from pediatric orthopedics and genetic counseling centers, generating per-test fees and institutional licensing agreements with sustained revenue growth.
Genetic Basis of Rare Metabolic Bone Disease Click to view more details →
Alkaline Phosphatase Deficiency Molecular Testing Marketplace
A digital marketplace connecting patients and clinicians with accredited laboratories offering targeted ALPL gene variant testing and interpretation services for hypophosphatasia diagnosis confirmation. The marketplace operates as a B2B2C platform generating transaction fees, provider commissions, and premium data analytics services that monetize aggregated genetic and clinical insights.
Genetic Basis of Rare Metabolic Bone Disease Click to view more details →
Progressive Familial Intrahepatic Cholestasis Gene Panel
Developing PFIC gene panels covering ATP8B1, ABCB11, ABCB4, TJP2, and NR1H4 for molecular diagnosis and IBAT inhibitor therapy selection.
Genetic Basis of Rare Liver Diseases Click to view more details →
Alagille Syndrome JAG1 and NOTCH2 Testing
Characterizing JAG1 and NOTCH2 pathogenic variants for Alagille syndrome diagnosis and correlating with hepatic, cardiac, and renal phenotype.
Genetic Basis of Rare Liver Diseases Click to view more details →
Citrin Deficiency SLC25A13 Gene Testing
Developing SLC25A13 testing for citrin deficiency causing neonatal intrahepatic cholestasis and adult-onset type II citrullinemia.
Genetic Basis of Rare Liver Diseases Click to view more details →
Hereditary Cholestasis Gene Discovery
Using WES for identifying novel cholestasis genes in patients with unexplained cholestatic liver disease not explained by known PFIC genes.
Genetic Basis of Rare Liver Diseases Click to view more details →
Wilson Disease ATP7B Mutation Detection SaaS Platform
A cloud-based diagnostic platform that automates ATP7B gene sequencing and variant interpretation for Wilson disease screening across clinical laboratories. This tool reduces turnaround time by 60% and enables labs to scale testing capacity while capturing per-test licensing revenue.
Genetic Basis of Rare Liver Diseases Click to view more details →
Hemochromatosis HFE and HJVP Commercial Genotyping Kit
A ready-to-use molecular diagnostic kit that identifies HFE and HJVP mutations associated with hereditary hemochromatosis for direct-to-consumer and clinical markets. This product generates recurring revenue through kit sales while establishing market dominance in iron overload genetic testing.
Genetic Basis of Rare Liver Diseases Click to view more details →
Alpha-1 Antitrypsin SERPINA1 Phenotyping Business Intelligence Tool
An integrated bioinformatics software that maps SERPINA1 variants to clinical phenotypes and predicts disease progression for personalized treatment planning. The platform monetizes through subscription licensing to pulmonology and hepatology clinics seeking data-driven patient management solutions.
Genetic Basis of Rare Liver Diseases Click to view more details →
Niemann-Pick Type C NPC1 and NPC2 Rapid Screening Service
A specialized genetic testing service that combines NPC1 and NPC2 gene analysis with lipid biomarker profiling to enable early disease detection in pediatric populations. This comprehensive service model creates high-margin revenue while reducing diagnostic odyssey time for families.
Genetic Basis of Rare Liver Diseases Click to view more details →
Tyrosinemia Type 1 FAH Gene Variant Interpretation Platform
A proprietary software platform that curates FAH gene variants and correlates genotypes with nitisinone response predictions for precision therapy selection. Revenue is generated through per-patient interpretation fees and white-label licensing to global diagnostic networks.
Genetic Basis of Rare Liver Diseases Click to view more details →
Mitochondrial Liver Disease mtDNA and nDNA Sequencing Marketplace
A centralized digital marketplace connecting patients with mitochondrial hepatopathy to specialized genetic testing labs offering combined mitochondrial and nuclear DNA analysis. This B2B2C platform captures transaction fees while aggregating clinical data to build proprietary disease outcome databases.
Genetic Basis of Rare Liver Diseases Click to view more details →